David R. Margrave insider trades
Open-market stock purchases and sales by David R. Margrave, Chief Financial Officer at Lantern Pharma Inc, from SEC Form 4 filings since Jun 15, 2020.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Dec 18, 2025 | LTRN Lantern Pharma Inc | Bought (not open market) | — |
Companies traded
- LTRN Lantern Pharma Inc: other filings, last Dec 18, 2025